School of Medicine
Showing 1-100 of 102 Results
-
Vishnu Priya Kanakaveti
Postdoctoral Scholar, Oncology
Current Research and Scholarly InterestsI am interested in elucidating molecular mechanisms of MYC-driven drug resistance and immune evasion in cancer using computational and experimental models.
-
Kathryn (Katie) Kapp
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsI am interested in using mass spectrometry to study protein glycosylation, a complex post-translational modification that is known to be heavily altered in cancer. Protein glycosylation could improve early cancer detection. I am using mass spectrometry to study protein glycosylation in a variety of clinical samples and cancers, but I am particularly interested in proximal fluid samples to develop sources of less invasive biomarkers.
-
Abraar Karan, MD MS MPH DTM&H
Instructor, Medicine - Infectious Diseases
Postdoctoral Medical Fellow, Infectious DiseasesBioI am an Instructor in the Division of Infectious Diseases and Geographic Medicine with affiliations in the Center for Innovation in Global Health, the King Center on Global Development, and the Woods Institute for the Environment. I worked on the Covid19 outbreak for the Massachusetts Department of Public Health in 2020, and the Monkeypox outbreak for the Los Angeles County Department of Public Health in 2022-23. I also served on the WHO-commissioned Independent Panel on Pandemic Preparedness and Response's research team investigating early global spread of Covid19, and helped with policy-writing for the Biden-Harris campaign on reducing Covid19 in schools. I am currently the Principal Investigator of the following studies: a cluster-randomized controlled trial investigating whether air filtration and ventilation can reduce spread of Covid19 in low-income homes in the Bay Area (https://clinicaltrials.gov/ct2/show/NCT05777720); utilizing multiplex assays for detecting exposures to filoviruses in Western Kenya; and assessing H5N1 seroprevalence in high-risk farmworker communities in California. I am also a co-investigator on a study focused on rtPCR based surveillance of H5N1 in humans in Central California.
I completed my internal medicine residency at the Brigham and Women's Hospital/Harvard Medical School in the Global Health Equity program, and have been working in global health since 2008. I co-edited the book, "Protecting the Health of the Poor" (December 2015, Bloomsbury Publishing, https://www.bloomsbury.com/us/protecting-the-health-of-the-poor-9781783605521/); and co-founded Longsleeve insect repellent, winner of the 2018 Harvard Business School New Venture Competition and finalist in the 2019 Harvard President's Challenge. Media/press coverage has included NBC, ABC, BBC, PBS, CBS, CNN, MSNBC, Fox News, Washington Post, New York Times, SF Chronicle, Bloomberg, Boston Globe, ProPublica, WSJ, TIME, Politico, CBC News, Democracy Now, NPR, ESPN, The Atlantic, The Hill, Business Insider, Vice, Mother Jones, Vox, Forbes, Slate, STAT News, MTV News, Mother Jones, Science Friday, TMZ.
For a full list of publications, please see "Publications" tab. For full list of press/media interviews, please see "Media" link.
Teaching Experience:
Teaching Assistant-- Epi 231, Infectious Disease Epidemiology (Winter 2024)
Teaching Assistant-- Epi 237, Practical Approaches to Global Health Research (Autumn 2024)
Teaching Assistant-- Epi 231, Infectious Disease Epidemiology (Winter 2025) -
Maira Karan
Postdoctoral Scholar, Psychiatry
BioMaira Karan is a postdoctoral fellow in the department of psychiatry and behavioral sciences, and a Pathyways to Neuroscience trainee through the Wu Tsai Neurosciences Institute. Her doctoral research focused on how positive human behaviors, such as empathy and prosociality, develop during the period of adolescence and how the adolescent brain and body mature in concert to support these other-oriented behaviors. Her research has utilized behavioral experiments, validated questionnaires, ecological momentary assessments, longitudinal assessments, and functional magnetic resonance imaging (fMRI). Another line of her work examines how sleep affects adolescent health and well-being with a special focus on circadian rhythms. At Stanford, she is working on merging her two lines of research to assess how sleep and circadian timing influence adolescent behaviors and health. In addition to conducting research, she has a deep passion for uplifting underrepresented individuals in(to) the fields of psychology and neuroscience, and she has a Certificate in Critical Consciousness & Anti-Oppressive Practices.
-
James Regun Karmoker
Postdoctoral Scholar, Ophthalmology
BioDr. James Regun Karmoker started his career as a Lecturer at the University of Asia Pacific, Bangladesh, after completing his B. Pharm and MS Pharm Tech from the same university. He obtained a doctorate degree in Vision Science from the University of Oklahoma, USA, where he studied immune cell activation in the context of retinal pigment epithelium injury. Currently, he is a postdoctoral scholar in Prof. Mary Elizabeth Hartnett’s lab studying age-related macular degeneration.
-
Siva Kasinathan
Instructor, Pediatrics - Rheumatology
BioSiva Kasinathan, MD, PhD is a physician-scientist and Instructor of Pediatric Rheumatology at the Stanford University School of Medicine and Lucile Packard Children's Hospital. In addition to caring for children and young adults with rheumatic diseases in his clinical practice, Siva conducts research to advance the understanding of mechanisms of autoimmunity and autoinflammation.
Siva holds an MD and PhD in Molecular and Cell Biology from the University of Washington, where he developed several high-throughput methods for epigenome profiling and contributed new insights in chromatin biology and gene regulation. During his clinical training in pediatrics and rheumatology at Stanford, Siva pioneered approaches for single-molecule analysis of genetic variation, DNA methylation, and chromatin structure, and established a longitudinal rheumatic disease cohort and biorepository.
Siva’s current research bridges genomics and immunology with a focus on developing and applying sensitive technologies to unravel the genetic and molecular underpinnings of lupus, arthritis, and other immune-mediated diseases. As a physician-scientist, Siva is committed to translating fundamental discoveries into precision therapies and biomarkers to improve outcomes for patients with rheumatic diseases. -
Aanchal Preet Kaur
Postdoctoral Scholar, Hematology-Oncology
BioDr. Aanchal Preet Kaur is a post-doctoral fellow in the Ramakrishna lab interested in understanding the role of myeloid cells in driving immunosuppression and resistance to CAR T cell therapies in pediatric patients with diffuse midline glioma. Her work involves developing organoid models to study the interaction of myeloid cells and CAR T cells and further employ these models to validate targets identified in patient single cell sequencing data using CRISPR technology.
Dr. Aanchal Preet Kaur received her PhD in Oncology at the University of Nottingham, United Kingdom where she focused on developing dendritic cell vaccines for melanoma. In her earlier post-doctoral work at Providence Cancer Institute with Dr. Michael Gough, she developed spheroid models to study the impact of radiation therapy on immune cell-cancer cell interactions. -
Koji Kawago
Postdoctoral Scholar, Cardiothoracic Surgery
Current Research and Scholarly InterestsWe propose a unique perfusion solution for Donation after Brain Death (DBD) and Donation After Cardiac Death (DCD) heart grafts.We will investigate the optimal timing and frequency of administration after retrieving the cardiac graft and achieve preclinical proof-of-concept of this perfusion solution for DBD and DCD cardiac graft using a heterotopic heart transplantation model.
-
Yujiro Kawai
Postdoctoral Scholar, Cardiothoracic Surgery
Current Research and Scholarly InterestsCardiovascular surgery, Translational research, Regenerative research, Heart failure, Tissue engineering, Heart transplant, Spinal cord ischemia, iPS cell,
-
Wayne Kepner
Postdoctoral Scholar, Psychiatry
BioWayne Kepner, PhD, MPH is a public health researcher whose scholarship focuses on health disparities and substance use among vulnerable populations. Dr. Kepner is currently a T-32 Post-doctoral Fellowship in Pain and Substance Use at Stanford University's School of Medicine, where he will continue his research under the mentorship of Dr. Keith Humphreys and Dr. Mark McGovern.
Dr. Kepner received his doctoral degree from the Joint Doctoral Program in Interdisciplinary Research on Substance Use at San Diego State University and the University of California, San Diego. His research focused on substance use disorders, health services utilization, and geospatial analysis of health data, with a particular emphasis on older adult populations. Dr. Kepner has extensive experience in both qualitative and quantitative research methods, having conducted interviews with older adults on cannabis use and analyzed large-scale electronic health records. He has co-authored several peer-reviewed publications on topics ranging from cannabis use trends to emergency department utilization for substance-related diagnoses. In addition to his academic work, Dr. Kepner is committed to community engagement, co-founding Aztecs For Recovery, a collegiate recovery program at SDSU. -
Arash Keshavarzi
Postdoctoral Scholar, Cardiovascular Medicine
BioArash Keshavarzi, PhD, has a background in Molecular Biology and AI drug discovery, with experience bridging AI and biotechnology. He used to be the CSO of Nucleus Genomics, a company that has raised over $30 million in funding from prominent investors including Founders Fund. He is the Co-founder of Lumos Bio, a UCSF spin-off focused on pioneering RNA-targeting cancer therapeutics, and also a co-founder of Entelligent.ai, driving innovation in AI driven intelligence. Additionally, Arash is actively involved in venture capital and investment as an Investment Fellow at Mubadala Capital, where he builds investment thesis, sources deals, and helps both biotech and AI teams. His career uniquely blends deep scientific expertise, entrepreneurial acumen, and strategic investment insights.
He has published over 10 academic papers in AI Therapeutics fields
He has published two book chapter in AI medicine
He has two patents in AI for small molecule drug discovery, one approved, one pending -
Bayan Kharrat
Postdoctoral Scholar, Developmental Biology
BioDr. Bayan Kharrat is a postdoctoral researcher in the Goins Lab at Stanford University School of Medicine, where she studies the mechanisms governing fate commitment in hematopoietic stem and progenitor cells in Drosophila, with a focus on identifying key regulatory factors involved in this process.
Dr. Kharrat earned her Ph.D. in Biology from the University of Szeged and conducted her graduate research at the HUN-REN Biological Research Centre in Szeged, where she investigated the dual role of Headcase, an imaginal cell factor, in maintaining progenitor cells in the larval lymph gland. Her expertise spans Drosophila genetics, developmental biology, molecular biology, and confocal microscopy. -
Pik Fang Kho
Postdoctoral Scholar, Cardiovascular Medicine
BioI obtained my PhD in genetic epidemiology at Queensland University of Technology (Australia), where my research was focused on using genetic and genomic approaches to identify risk factors for endometrial cancer. During my graduate studies, I gained experience in large-scale genetic association studies and leveraging the correlation between diseases in genetic studies to identify novel genetic variants associated with endometrial cancer. I also developed expertise in various statistical genetic approaches in multi-omics data, including fine-mapping and colocalization analyses, to prioritize candidate causal variants and genes. I also gained extensive experience in genetic causal inference analysis to infer causality between risk factors and health outcomes.
My research focus since moving to Stanford has been the identification of genetic and non-genetic determinants of cardiometabolic diseases. I am currently involved in projects including large-scale genetic association studies, multi-trait analysis with correlated traits, development and validation of polygenic risk scores, integrative analyses with multi-omics data, as well as Mendelian randomization analyses to advance our understanding of the genetic and environmental factors that contribute to cardiometabolic diseases. -
Donghoon Kim
Postdoctoral Scholar, Radiology
BioDr. Donghoon Kim is a postdoctoral scholar at Stanford's Center for Advanced Functional Neuroimaging. His research focuses on developing cutting-edge techniques for analyzing multimodal neuroimaging using deep learning-based methods.
Before joining Stanford, he earned his Ph.D. in Biomedical Engineering from University of California, Davis. His Ph.D. thesis was titled "Deep Learning-Driven Technical Developments and Clinical Applications of Arterial Spin Labeling MRI". During his Ph.D. studies, he focused on the development of advanced deep learning techniques for ASL MRI, and its clinical applications. During his master's degree in Biomedical Engineering at Virginia Tech-Wake Forest University, he studied the functional connectivity of the default mode network using resting state BOLD fMRI among youth football players. -
Jiyeong Kim
Postdoctoral Scholar, Dermatology
BioDr. Jiyeong Kim is a post-doctoral scholar at the Stanford Center for Digital Health and the Department of Dermatology School of Medicine. As a multi-disciplined data scientist, Dr. Kim applies artificial intelligence (AI) to clinical informatics, harnessing patient-generated health information and data to enhance patient-centered care, which could be tailored to each patient group for improving patient engagement and better health outcomes. In her work, Dr. Kim leverages large language models, machine learning, and natural language processing to understand patients' and caregivers' genuine voices of care needs and needed support for individuals with chronic diseases, not limited to diabetes, cardiovascular disease, and cancer.
Research Interest
-LLMs and Generative AI to Listen to the Patient
-Generative AI-Assisted Enhanced Patient Care
-ML-based Disease Prediction Modeling
-Patient-Generated Data and Precision Health -
Samsuk Kim, PhD.
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioDr. Samsuk Kim is a dual research and clinical T32 fellow at Stanford University. She earned her PhD in Clinical Psychology from the University of Detroit Mercy and completed external research training at the University of Michigan (Kratz Lab), where she studied psychosocial factors—such as mindfulness and pain acceptance—in chronic pain. She also completed an APA-accredited internship at the VA Boston Healthcare System. Clinically, Dr. Kim specializes in pain management, health promotion, adjustment-related challenges, and emotional regulation. She draws from a range of evidence-based treatments, including Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), mindfulness-based interventions, Dialectical Behavior Therapy (DBT), and interpersonal psychotherapy. Her current research focuses on understanding the bidirectional relationship between sleep and pain and developing personalized, digital interventions to improve outcomes in both domains.
-
Maximilian Koch
Postdoctoral Scholar, Stanford Cancer Institute
Current Research and Scholarly InterestsMy current research focuses on developing novel cellular immunotherapies for pediatric cancers. This includes identifying suitable MHC-restricted and native antigens that are expressed by malignant cells but ideally absent from healthy tissues. On the receptor side, both CARs and TCRs are being characterized for their specificity, affinity, and functionality. Ultimately, non-viral gene delivery methods will be explored and optimized to enable affordable, precise, and consistent cell products.
-
Gabriele Kockelkoren
Postdoctoral Scholar, Genetics
BioGabriele has a strong background in both physics and molecular biology and, accordingly, he strives in interdisciplinary environments. After completing a cum laude BSc. and MSc. in Nanobiology at the Technical University of Delft in The Netherlands, Gabriele pursued a PhD at the University of Copenhagen under the supervision of Prof. Dimitrios Stamou. In his PhD, Gabriele studied the nanoscale spatial organization of G protein-coupled receptors (GPCRs) at the plasma membrane of living cells. Importantly, his work reveals heterogeneous spatial patterns of receptor density and activation, that are modulated in a drug-dependent manner. These findings identify GPCR spatial organization as an integral element of their activity and signaling. Currently, Gabriele is a Postdoctoral Fellow in the lab of Prof. Alice Ting developing programmable receptors for molecular sensing and controlling cellular behaviour.
-
Praneeta R. Konduri
Postdoctoral Scholar, Neurology and Neurological Sciences
BioDr. Konduri is a Postdoctoral scholar at the Department of Neurology and Neurological Sciences. With a background in biomedical engineering, she conducted her PhD research as part of a European consortium that developed computational stroke models, while also analyzing post-treatment brain tissue damage from multicenter clinical trials to assess prognosis. After completing her PhD, she continued as a Postdoctoral Researcher within the European consortium GEMINI, that aimed to implement digital twins for personalized stroke treatment. At the Stanford Stroke Center, she now focusses on developing AI tools for stroke diagnosis, treatment evaluation, prognostication, and personalized treatment development.
-
Qinqin Kong
Postdoctoral Scholar, General Internal Medicine
BioI am currently a Postdoctoral Scholar in the Departments of Medicine and Health Policy at Stanford University, after earning a PhD in atmospheric science from Purdue University. My research interests lie at the intersection of climate change—particularly extreme heat—and human society. I aim to advance our understanding of the physical mechanisms, cascading impacts, and the effectiveness of potential mitigation strategies for human heat stress. My PhD research focused on how land-atmosphere interactions modulate heat stress, as well as the economic and energy impacts of increasing heat stress in the context of climate change. My postdoctoral research at Stanford evaluates the impact of heat stress on public health, especially human fertility, in low- and middle-income countries. My methodological areas of expertise include climate modeling, human biophysics modeling, and econometric modeling, which I am further developing at Stanford.
-
Naoki Konno
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsI aim to decipher evolutionary patterns and rules in developmental processes of multicellular organisms by leveraging single-cell and spatial omics technologies.
-
Izabela Kowalczyk
Postdoctoral Scholar, Developmental Biology
BioDr. Izabela Kowalczyk is a postdoctoral fellow in the laboratory of Dr. Sarah Bowling, Department of Developmental Biology. She is studying embryonic development, with a focus on heart valve formation and the influence of the maternal environment on this process. Dr. Kowalczyk completed her Ph.D. at the Max-Delbrück-Center for Molecular Medicine in Berlin, under the supervision of Dr. Annette Hammes, where she investigated cell and tissue morphogenesis during early forebrain development. Her work identified novel components of Sonic Hedgehog (SHH) signaling and primary cilia biology, providing new insights into the variable penetrance of holoprosencephaly in mouse models.
-
Manoj Kumar
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsI work on imaging-guided therapy using PET and MR imaging approaches. My academic training and background is in molecular imaging. During my doctoral training, I developed and validated a PET imaging approach for evaluating endocrine therapy responses in advanced breast cancer. My current research focuses on imaging tumor immune markers and responses to cancer immunotherapy. The goal is to develop new imaging toolboxes to monitor and guide treatment. Specifically, I employ antibodies, nanoparticles, and reporter genes for imaging and combinations of therapies to modulate and restore the body's suppressed immune functions against cancer cells. This is being done in collaboration with teams of researchers in early clinical development and teams in clinical practice.
